MM-514 Vactosertib, a Novel Transforming Growth Factor Beta (TGFß) Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness: A Single-Arm, Phase Ib Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
- Resource Type
- Abstract
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S505-S506 - Subject
- Language
- ISSN
- 2152-2650